HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- ol

a B-raf kinase inhibitor with antineoplastic activity; structure in first source
Also Known As:
GDC 0879; GDC-0879; GDC0879
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Seshagiri, Somasekar: 2 articles (08/2014 - 04/2009)
2. Belvin, Marcia: 2 articles (04/2009 - 04/2009)
3. Wong, Leo: 2 articles (04/2009 - 04/2009)
4. Herter, Sylvia: 2 articles (04/2009 - 04/2009)
5. Hoeflich, Klaus P: 2 articles (04/2009 - 04/2009)
6. Wang, Weiru: 1 article (08/2014)
7. Mooz, Juliane: 1 article (08/2014)
8. Rajalingam, Krishnaraj: 1 article (08/2014)
9. Jaiswal, Bijay S: 1 article (08/2014)
10. Harms, Gregory S: 1 article (08/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
2. MAP Kinase Kinase 1
3. Mitogen-Activated Protein Kinase 3
4. sorafenib (BAY 43-9006)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)